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Abstract
Background: The purpose of this study was to investigate the relationship between hormone replacement therapy
(HRT) and periodontal disease in postmenopausal women using data from the 4th and 5th Korea National Health
and Nutrition Examination Survey (KNHANES).
Methods: The study included data from 5,482 postmenopausal women aged 45–74 years in the 2007–2012
KNHANES. The use of female HRT for at least one month was reclassified as HRT+/HRT-. The Community
Periodontal Index of Treatment Needs (CPITN) was used to assess periodontal status. Propensity score matching
(PSM) was used to control selection bias, and factors affecting education, family income, and age of menopause
were used as covariates in PSM. A chi-square test was used to confirm the bivariate relationship between the
variables. Binary logistic regression analysis was used to adjust for confounders (age, education, family income, body
mass index, age of menopause, alcohol, smoking, dental clinic visits in the past one year, use of oral care products
and frequency of tooth brushing per day).
Results: After adjusting for all covariates, HRT was associated with periodontal disease (OR: 0.79; 95% CI: 0.66–0.94).
In particular, the relationship between HRT and periodontal disease was more evident in those with menopause
under 45 years of age disease (OR: 0.55; 95% CI: 0.35–0.87).
Conclusions: The results of this study supported that it is important that hormone therapy be actively considered
in the policy towards postmenopausal women. Especially, health programs such as hormone replacement therapy,
non-smoking, and use of oral care products are needed for women who undergo premature menopause.
Keywords: Hormone replacement therapy, Menopause, Periodontal disease
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: inahkim@hanyang.ac.kr
2Department of Occupational and Environment Medicine, College of
Medicine, Hanyang University, 222 wangsimni-ro, Seongdong-gu, Seoul,
Republic of Korea
Full list of author information is available at the end of the article
Lee et al. BMC Oral Health          (2019) 19:151 
https://doi.org/10.1186/s12903-019-0839-9
Background
The World Health Organization (WHO) defines natural
menopause as 12 months of consecutive amenorrhea
without an apparent cause, such as pregnancy or lacta-
tion [1]. While menopausal age varies between individ-
uals and races, the average menopausal age for countries
has been reported to be around 50 years [2]. The average
menopausal age of women in Korea is 49.7 years. Con-
sidering that the life expectancy of Korean women was
85.2 years in 2015 [3], Korean women are expected to
spend over one-third of their life, or approximately 35.5
years, in the menopausal state [4]. Menopause is a
phenomenon that occurs naturally with aging, but post-
menopausal women face increased risk of various diseases,
including osteoporosis and cardiovascular diseases [5].
Postmenopausal women experience a rapid decrease
in bone mineral density (BMD) due to hormone (estro-
gen) deficiency [6]. Meanwhile, Osteoporosis and peri-
odontal diseases are indicative of excessive bone
resorption, as both diseases have host-dependent, multi-
factorial causes and are regulated by local and systemic
cytokines, such as IL-1 and 6, and various hormones [7].
When the periodontal status of menopausal women with
osteoporosis was investigated, more severe periodontal
pocket depth and attachment loss was found compared
to those in the same age group who did not have osteo-
porosis [8]. In particular, menopause-related hormonal
changes are known to affect the oral environment, due
to changes in sex hormones, such as estrogen, progester-
one, and testosterone, which have an impact on the
secretion of proinflammatory cytokines that are involved
in bone resorption [9]. Moreover, estrogen receptors in
the oral mucosa react sensitively to changes in hormone
levels, which leads to increased inflammation in the
periodontal tissues [10].
The need for hormone replacement therapy (HRT)
was presented as a means to alleviate menopausal symp-
toms so that a woman’s quality of life can be improved
during menopause [11]. HRT plays an important role in
preventing osteoporosis by reducing postmenopausal
bone mass loss [12]. Menopausal women who received
estrogen therapy showed a significantly increased density
in their lumbar spine and femur, as compared to the
control group; while, similar results were found in the
alveolar bone as well [13]. Postmenopausal HRT is
widely recognized to prevent osteoporosis and improve
menopause-related diseases [14]. Since periodontal dis-
eases are also affected by the state of the alveolar bone,
various studies have attempted to demonstrate the asso-
ciation between HRT and periodontal disease [15–19].
However, the effects of HRT varied according to meno-
pausal age and the postmenopausal period, while also
showing conflicting results according to the extent of
periodontal disease progression [15, 16]. In other words,
HRT may have a positive effect on alveolar bone density,
but it was reported to have no relationship with the at-
tachment level of periodontal tissues and periodontal
pocket depth [17–19]. Although it is believed that HRT
applied to postmenopausal women was related to peri-
odontal disease based on its mechanism, existing studies
regarding the relationship between HRT and periodontal
disease have produced inconsistent results. Accordingly,
the objective of the present study was to identify the
relationship between HRT and the risk of periodontal
disease in postmenopausal women by using data from
the Korea National Health and Nutrition Examination
Survey (KNHANES) IV and V. The study aimed to
analyze the association between HRT and the risk of
periodontal diseases in menopausal women to provide
basic data that can be used to establish oral health
policies for menopausal women according to their life
stages. For this, the study aimed to increase internal
validity by using propensity score matching (PSM) to
adjust for confounding factors and selection bias attrib-
utable to observational studies.
Methods
Study data and study population
The present study used data from the fourth (2007–
2009) and fifth (2010, 2012) KNHANES conducted by
the Korea Centers for Disease Control and Prevention, with
exemption from review (HYI-16-195) by the Institutional
Review Board (IRB) at Hanyang University. KNHANES
data were collected using stratified, clustered, and system-
atic sampling [20]. The sampling method was adjusted for
the number of households while accounting for region, type
of residence, and administration district in the Republic of
Korea [21]. KCDC has published the Korea Health Statis-
tics each year, and microdata are publicly available through
the KNHANES website (http://knhanes.cdc.go.kr). Based
on the data from subjects who completed their health
questionnaire survey and health examination, the study
population was limited to menopausal women who were
defined as having 12months of consecutive amenorrhea
without apparent cause, such as pregnancy or lactation
[22]. Cases involving artificial menopause due to surgeries
or diseases were excluded. Moreover, based on the criteria
for normal menopausal age given by the Korean Society of
Menopause, only women between the ages of 45 and 74
years old were included. Among the total of 5,482
women selected by the method above, a total of 2,070
women (1,035 in the HRT group and 1,035 in the
non-HRT group, based on matching results) were
selected for the final analysis.
Questionnaire survey
As the dependent variable, the community periodontal
index of treatment needs (CPITN) that has a score range
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of 0–4 points was reclassified as “No” (0–2) and “Yes”
(3–4) to periodontal disease. CPITN is an index that
demonstrates the need for periodontal treatment in a
specific cohort or entire population of a local commu-
nity, providing guidelines for understanding the status of
periodontal health in a local community, establishing a
periodontal treatment plan, and ensuring effective usage
of periodontal treatment resources [23]. For the inde-
pendent variable, the use of female HRT for at least one
month was reclassified as HRT+/HRT-. The study also
categorized and used the following confounding vari-
ables: general characteristics, such as age (45–54, 55–64,
65–74 years old), education (elementary and below, mid-
dle, high and above), family income (low, middle-low,
middle-upper, upper), body mass index (normal, obese)
and age of menopause (< 45, ≥45 years old); lifestyle
habits, such as alcohol (non-drinker, past drinker,
current drinker) and smoking (non-smoker, smoker);
and oral care status, such dental clinic visits in the past
year (yes, no), use of oral care products (yes, no), and
frequency of tooth brushing per day (< 3, ≥3 times).
Statistical analysis
When analyzing the association between HRT and peri-
odontal disease, propensity score matching (PSM) was
used for balancing by controlling the covariates. Propen-
sity score matching is a method that equates treatment
and control groups on a comprehensive set of measured
confounders in observational studies [24]. PSM is a sin-
gle numerical value of probability that summarizes the
selected confounder, using logistic regression analysis.
For this analysis, HRT was the dependent variable, while
education level, family income level, and age of meno-
pause were used as covariates. Based on the propensity
scores estimated in this manner, HRT+ and HRT-
groups were matched 1:1 by the nearest matching neigh-
bor. Before matching, the study population included a
total of 5,482 women (4,447 in the HRT- and 1,035 in
the HRT+ groups). After PSM, a total of 2,070 women
were included (1,035 in the HRT+ and 1,035 in the
HRT- groups) (Fig. 1).
To verify that matching was successful, differences be-
tween the confounding variables based on HRT+/HRT-
were tested by the chi-square test. Moreover, binary
logistic regression analysis was performed to identify the
factors associated with HRT and periodontal disease,
and from these results, the adjusted odds ratio (Adjusted
OR) and 95% confidence interval (CI) were presented.
The statistical significance level was set to p < 0.05. Ana-
lysis was also performed with inclusion of interaction
variables to examine the interaction effects between
HRT and age of menopause. STATA 11.0 (StataCorp LP,
TX, USA) was used for all analyses.
Results
Analysis of differences before and after propensity score
matching
After matching for education level, household income,
and age of menopause, based on the analysis of differences
before and after PSM of all study populations, pre-
matching differences in covariates according to HRT+/
HRT- are shown on the left side and post-matching differ-
ences are shown on the right side. Before matching, the
total study population included 5,482 women; 4,447 in the
HRT- group with no experience of HRT and 1,035 in the
HRT+ group with previous experience with HRT. After
matching, the study population was narrowed to 2,070
women, with 1,035 each in HRT- and HRT+ groups. Be-
fore matching, there was a significant difference in HRT
status based on education, family income, periodontal
disease, age, body mass index, drinking, dental clinic visits
in the past 1 year, use of oral care products, and frequency
of tooth brushing per day. After matching, there was a
significant difference in HRT status based on periodontal
disease, age, drinking, and use oral care products. Vari-
ables that exhibited differences based on HRT+/− prior to
matching – including education level, household income,
and age of menopause – no longer showed differences
based on HRT+/− after matching, suggesting that PSM
has been successfully completed (Table 1).
Comparison of existence of periodontal diseases
according to the general characteristics of the subjects
The association between the general characteristics of
the subjects and periodontal diseases after PSM showed
Fig. 1 Flow chart of study population.
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statistically significant differences based on HRT status,
education, family income, smoking, use of oral care
products, and frequency of tooth brushing per day. The
HRT- group(39.23%) showed a higher prevalence of
periodontal disease than the HRT+ group(33.72%).
Moreover, the prevalence of periodontal diseases was
higher in those with a lower education level and house-
hold income, as well as those who were smokers, did
not use oral care products, and brushed their teeth < 3
times a day (Table 2).
Factors associated with periodontal status
The binary logistic regression analysis regarding factors
associated with the general characteristics of the sub-
jects, periodontal disease, and HRT status after Propen-
sity score matching showed that the HRT+ group had
an adjusted OR of 0.79 (95% CI: 0.66–0.94) for those
with periodontal disease, as compared to the HRT-
group. The analysis including the interaction variables
for interaction effects between HRT status and age of
menopause after adjusting for all other factors showed
that the premature menopause HRT+ group had an
adjusted OR of 0.55 (95% CI: 0.35–0.87) for those with
periodontal disease, as compared to the premature
menopause HRT- group, while the adjusted OR for those
with periodontal disease was 0.71 (95% CI: 0.50–1.00)
and 0.60 (95% CI: 0.42–0.85) in the normal menopause
HRT- and HRT+ groups, respectively. The upper house-
hold income group had an adjusted OR of 0.74 (95% CI:
0.55–0.99) for those with periodontal disease, as com-
pared to the low household income group. Meanwhile,
the adjusted OR for those with periodontal disease in
Table 1 Analysis of differences before and after propensity score matching
Characteristics Group Before matching (5,482) After matching (2,070)
HRT- (4,447) HRT+ (1,035) ×2 HRT- (1,035) HRT+ (1,035) ×2
Education Elementary and below 2,785 (62.63) 460 (44.44) < 0.001*** 460 (44.44) 460 (44.44) 1.000
Middle 693 (15.58) 218 (21.06) 218 (21.06) 218 (21.06)
High and above 969 (21.79) 357 (34.49) 357 (34.49) 357 (34.49)
Family incomea Low 1,543 (34.70) 214 (20.68) < 0.001*** 214 (20.68) 214 (20.68) 1.000
Middle low 1,228 (27.61) 289 (27.92) 289 (27.92) 289 (27.92)
Middle upper 867 (19.50) 251 (24.25) 251 (24.25) 251 (24.25)
Upper 809 (18.19) 281 (27.15) 281 (27.15) 281 (27.15)
Age of menopause(y) < 45 637 (14.32) 163 (15.75) 0.242 163 (15.75) 163 (15.75) 1.000
≥45 3,810 (85.68) 872 (84.25) 872 (84.25) 872 (84.25)
Periodontal disease No 2,657 (59.75) 686 (66.28) < 0.001*** 629 (60.77) 686 (66.28) 0.009**
Yes 1,790 (40.25) 349 (33.72) 406 (39.23) 349 (33.72)
Age (y) 45–54 990 (22.26) 265 (25.60) < 0.001*** 331 (31.98) 265 (25.60) < 0.001***
55–64 1,726 (38.81) 516 (49.86) 394 (38.07) 516 (49.86)
65–74 1,731 (38.93) 254 (24.54) 310 (29.95) 254 (24.54)
Body mass indexb Normal 2,662 (59.86) 655 (63.29) 0.042* 654 (63.19) 655 (63.29) 0.964
Obese 1,785 (40.14) 380 (36.71) 381 (36.81) 380 (36.71)
Alcohol No 1,459 (32.81) 266 (25.70) < 0.001*** 321 (31.01) 266 (25.70) 0.019*
Past 1,868 (42.01) 449 (43.38) 432 (41.74) 449 (43.38)
Drinking 1,120 (25.19) 320 (30.92) 282 (27.25) 320 (30.92)
Smoking No 4,127 (92.80) 963 (93.04) 0.788 961 (92.85) 963 (93.04) 0.864
Yes 320 (07.20) 72 (06.96) 74 (07.15) 72 (06.96)
Dental visit < 1 years No 3,531 (79.40) 741 (71.59) < 0.001*** 760 (73.43) 741 (71.59) 0.351
Yes 916 (20.60) 294 (28.41) 275 (26.57) 294 (28.41)
Use of oral care products No 3,337 (75.04) 627 (60.58) < 0.001*** 685 (66.18) 627 (60.58) 0.008**
Yes 1,110 (24.96) 408 (39.42) 350 (33.82) 408 (39.42)
Frequency of tooth brushing per day < 3 2,852 (64.13) 608 (58.74) 0.001** 581 (56.14) 608 (58.74) 0.231
≥3 1,595 (35.87) 427 (41.26) 454 (43.86) 427 (41.26)
HRT hormone replacement therapy
a Income quartile. bAsia-Pacific Standard: normal, less than 25 kg/m2; obese, more than 25 kg/m2
*p < 0.05, **p < 0.01, ***p < 0.001
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those who responded “Yes” to smoking and the use of
oral care products was 2.04 (95% CI: 1.44–2.89) and 0.78
(95% CI: 0.63–0.95), respectively (Table 3).
Discussion
After adjusting for various potential factors associated
with periodontal diseases, the study found that HRT and
periodontal diseases were associated. The analysis of
menopausal women aged between 45 and 74 years old
showed that the HRT+ group was less likely to develop
periodontal diseases than the HRT- group, which sup-
ported the results of previous studies. In a case-control
study by Haas et al. that examined Brazilian women aged
40~69 years old, the likelihood of periodontal diseases in
the group who did not undergo HRT during menopause
was 2.10 times higher than the pre-menopausal women;
while, the likelihood of the group who underwent HRT
during menopause was 1.11 times higher than the pre-
menopausal women. These results show a similar con-
text to the present study and HRT may be viewed as an
option for lowering the risk of exacerbating periodontal
status. However, a study by Pizzo et al. evaluating 91
Italian menopausal women aged 50~62 years reported
that there was no difference in periodontal pocket depth
between the group who underwent HRT and the group
who did not, but the group who did not undergo HRT
had a higher plaque level. A case-control study by
López-Marcos et al. [25] on 210 Spanish menopausal
women aged 40–58 years reported that the estrogen
patch group showed a reduction in periodontal pocket
depth, but since an association with receding gums
could not be found, further consideration was needed on
Table 2 General characteristics of the subjects and periodontal disease after propensity score matching (n = 2,070)
Characteristics Group Periodontal disease X2
No (N = 1,315) Yes (N = 755)
HRT status HRT- 629 (60.77) 406 (39.23) 0.009**
HRT+ 686 (66.28) 349 (33.72)
Age(y) 45–54 395 (66.28) 201 (33.72) 0.089
55–64 581 (63.85) 329 (36.15)
65–74 339 (60.11) 225 (39.89)
Education Elementary and below 542 (58.91) 378 (41.09) < 0.001***
Middle 287 (65.83) 149 (34.17)
High and above 486 (68.07) 228 (31.93)
Family incomea Low 255 (59.58) 173 (40.42) < 0.001***
Middle low 350 (60.56) 228 (39.45)
Middle upper 309 (61.55) 193 (38.45)
Upper 401 (71.35) 161 (28.65)
Body mass indexb Normal 850 (64.94) 459 (35.06) 0.081
Obese 465 (61.11) 296 (38.9)
Age of menopause(y) < 45 197 (60.43) 129 (39.57) 0.206
≥45 1118 (64.11) 626 (35.89)
Alcohol consumption No 364 (62.01) 223 (37.99) 0.662
Past 566 (64.24) 315 (35.75)
Drinking 385 (63.95) 217 (36.05)
Smoking No 1247 (64.81) 677 (35.19) < 0.001***
Yes 68 (46.58) 78 (53.42)
Dental visit < 1 years No 953 (63.49) 548 (36.51) 0.956
Yes 362 (63.62) 207 (36.38)
Use of oral care products No 791 (60.29) 521 (39.71) < 0.001***
Yes 524 (69.13) 234 (30.87)
Frequency of tooth brushing per day < 3 726 (61.06) 463 (38.94) 0.007**
≥3 589 (66.86) 292 (33.14)
HRT hormone replacement therapy
aIncome quartile. bAsia-Pacific Standard: normal, less than 25 kg/m2; obese, more than 25 kg/m2
**p < 0.01, ***p < 0.001
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this topic. These conflicting study results may exist be-
cause of varying clinical assessment tools for age group,
menopausal period, and periodontal status.
According to precedent studies, subjects in the same
age group showed differences in the effects of HRT de-
pending on the menopausal period. Singh et al. [26],
Richa et al. [27] reported that the effects of estrogen
were greater in people with a longer menopausal period
and lower bone mass. Meanwhile, women with prema-
ture menopause occurring before the average meno-
pausal age of 50 were reported to have a higher risk of
osteoporosis, cardiovascular disease, and associated
mortality rate than women with normal menopause due
to having a longer period of estrogen deficiency [28]. A
prospective study by Women’s Health Initiative (WHI)
compared BMD after dividing the subjects into groups of
menopausal age of < 40 and ≥ 40 years. The results showed
that the < 40-year-old group had a statistically significantly
lower BMD and the risk of fracture was also higher in the
premature menopause group [29]. Sullivan et al. [30] re-
ported that among women who did not undergo HRT,
those who experienced menopause at an earlier age
tended to have a high risk of fracture and reduction in
BMD, while Faubion et al. [31] reported that women with
early estrogen deficiency had the need for estrogen ther-
apy with a higher dose due to increased risk of reduction
in BMD and death than normal menopausal women.
In the present study, the effects of HRT were more
evident in women with premature menopause, before
the age of 45 years, which supported the findings in
existing studies. This occurs because the effects of HRT
are more prominent in premature menopausal women
because they have a lower BMD for a longer period of
estrogen deficiency, which was consistent with a 3-year
prospective study by PEPI, in which the patient age and
pre-treatment BMD were the factors associated with an
increase in post-HRT BMD [32].
In the present study, In this study, the ‘upper’ house-
hold income group exhibited lower prevalence of peri-
odontal disease, while smokers and users of oral hygiene
products exhibited higher prevalence of periodontal
disease. Such results were similar to the findings in
studies by Schuch et al. [33] where people with a higher
education level and income tended to have a higher rate
of undergoing treatment for periodontal disease.
MacFarlane et al. [34] have reported that patients with
chronic periodontal disease showed impaired phagocytic
function compared to those who managed the average
adhesion an ingestion of polymorphonuclear leukocytes.
Reduction in BMD caused by smoking is especially
evident in menopausal women [35]. These results are
connected to the effects of HRT appearing more prom-
inently when the periodontal status is poorer. Based on
the aforementioned results, it is determined that for pre-
mature menopause, HRT should be seriously considered
due to an increased risk of bone loss and periodontal
disease caused by prolonged estrogen deficiency. More-
over, HRT may be more effective in premature meno-
pausal women with a poor periodontal status.
The present study aimed to be highly representative of
Korea by using the KNHANES data that measured the
periodontal status according to WHO criteria. However,
because it was a cross-sectional study, there were limita-
tions because causal relationships between the influen-
cing factors and the onset of periodontal disease could
not be identified and the duration of HRT was not con-
sidered. Compared to existing studies, the significance of
Table 3 Association between HRT and periodontal disease
(n = 2,070)










Age 55–64 1.09 0.86–1.38
65–74 1.08 0.82–1.42
Education Elementary and below 1.000
Middle 0.85 0.66–1.09
High and above 0.85 0.67–1.08
Family income Low 1.000
Middle low 1.05 0.81–1.37









Dental visit < 1 years No 1.000
Yes 1.12 0.91–1.38








HRT hormone replacement therapy
a Income quartile bAsia-Pacific Standard: normal, less than 25 kg/m2; obese,
more than 25 kg/m2
*p < 0.05, **p < 0.01, ***p < 0.001
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the present study can be found in that it used CPITN,
an objective periodontal status assessment tool, and that
various factors such as age, age at menopause, and oral
care behavior were adjusted to analyze the association
between HRT and periodontal disease with consideration
for a more diverse set of factors.
Conclusions
The present study was performed to identify the associ-
ation between HRT and periodontal disease in meno-
pausal women in Korea by using the data from the
KNHANES IV and V. The study used CPITN as an
objective assessment tool for periodontal status and ad-
justed for various factors, such as age, menopausal age,
and oral care behavior to more definitively identify the
association between HRT and periodontal disease. The
results showed that HRT was associated with a lower
risk of periodontal disease. Such effect was more evident
in women who experienced premature menopause, did
not maintain proper oral care, had a lower income level,
and were smokers. Therefore, when establishing oral
health policies for menopausal women, serious consider-
ation should be given to HRT. Moreover, healthcare pro-
grams involving HRT, regular dental check-ups, and oral
care need to be implemented especially for premature
menopausal women who are smokers.
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